ZA938896B - Antioxidant cardioprotective use of and method of treatment using hydroxycarbazole compounds - Google Patents

Antioxidant cardioprotective use of and method of treatment using hydroxycarbazole compounds

Info

Publication number
ZA938896B
ZA938896B ZA938896A ZA938896A ZA938896B ZA 938896 B ZA938896 B ZA 938896B ZA 938896 A ZA938896 A ZA 938896A ZA 938896 A ZA938896 A ZA 938896A ZA 938896 B ZA938896 B ZA 938896B
Authority
ZA
South Africa
Prior art keywords
treatment
antioxidant
hydroxycarbazole
compounds
hydroxycarbazole compounds
Prior art date
Application number
ZA938896A
Other languages
English (en)
Inventor
Frank C Barone
Giora Feuerstein
Tian-Li Yue
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA938896B publication Critical patent/ZA938896B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Paper (AREA)
  • Indole Compounds (AREA)
ZA938896A 1992-12-01 1993-11-29 Antioxidant cardioprotective use of and method of treatment using hydroxycarbazole compounds ZA938896B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98391692A 1992-12-01 1992-12-01

Publications (1)

Publication Number Publication Date
ZA938896B true ZA938896B (en) 1994-08-01

Family

ID=25530177

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938896A ZA938896B (en) 1992-12-01 1993-11-29 Antioxidant cardioprotective use of and method of treatment using hydroxycarbazole compounds

Country Status (9)

Country Link
US (1) US5405863A (cg-RX-API-DMAC10.html)
EP (1) EP0671913A1 (cg-RX-API-DMAC10.html)
JP (1) JPH08503710A (cg-RX-API-DMAC10.html)
KR (1) KR950703949A (cg-RX-API-DMAC10.html)
CN (1) CN1043509C (cg-RX-API-DMAC10.html)
AU (1) AU675481B2 (cg-RX-API-DMAC10.html)
CA (1) CA2150694A1 (cg-RX-API-DMAC10.html)
WO (1) WO1994012177A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA938896B (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0907318A4 (en) * 1996-04-29 2000-02-02 Smithkline Beecham Corp ANTIOXIDING COMPOUND
KR20000048967A (ko) 1996-10-09 2000-07-25 제이 베리 부조가니 스트레스-활성화 단백질 키나제의 억제 방법
JP4126345B2 (ja) * 1997-03-06 2008-07-30 松森　　昭 ウイルス感染症の予防・治療剤
US20020054911A1 (en) * 2000-05-11 2002-05-09 Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi Novel oral dosage form for carvedilol
WO2000007584A2 (en) 1998-08-04 2000-02-17 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20050148779A1 (en) * 2002-04-30 2005-07-07 Wei Chen Carvedilol monocitrate monohydrate
EP1539140A4 (en) * 2002-06-27 2005-12-07 Sb Pharmco Inc CARVEDILOLHYDOBROMID
AU2003248746B2 (en) * 2002-06-27 2009-01-08 Smithkline Beecham (Cork) Limited Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
US20050020666A1 (en) * 2003-07-25 2005-01-27 Dabur Research Foundation Cardioprotective agents
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
JP5072364B2 (ja) * 2003-11-25 2012-11-14 スミスクライン ビーチャム （コーク） リミテッド カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
US20090076116A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched carvediolo
US10281374B2 (en) * 2015-11-04 2019-05-07 Diagnostic Biosystems Method of pretreatment of biological samples for an analyte-staining assay method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4438559A (en) * 1980-06-27 1984-03-27 Fuji Machine Mfg. Co. Ltd. Apparatus for automatically mounting non-lead electronic components on printed-circuit

Also Published As

Publication number Publication date
AU5732294A (en) 1994-06-22
EP0671913A4 (cg-RX-API-DMAC10.html) 1995-10-25
CN1098909A (zh) 1995-02-22
AU675481B2 (en) 1997-02-06
US5405863A (en) 1995-04-11
CN1043509C (zh) 1999-06-02
JPH08503710A (ja) 1996-04-23
CA2150694A1 (en) 1994-06-09
EP0671913A1 (en) 1995-09-20
KR950703949A (ko) 1995-11-17
WO1994012177A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
ZA938896B (en) Antioxidant cardioprotective use of and method of treatment using hydroxycarbazole compounds
GB2269164B (en) Treatment of polyvinylchloride
ZA931778B (en) Method and composition for the treatment of osteoporosis
GB9027968D0 (en) Method of treatment
GB9014307D0 (en) Method of treatment and compositions therefor
GB9218027D0 (en) Novel method of treatment
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
GB2283485B (en) Treatment of sludge
GB9202196D0 (en) Method of treatment
ZA938897B (en) Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds
GB9201391D0 (en) Method of treatment
GB9218597D0 (en) Novel method of treatment
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
ZA93491B (en) Treatment of psychoses
GB9202020D0 (en) Method of treatment
GB9202698D0 (en) Method of treatment
GB9226252D0 (en) Method of treatment
GB9223252D0 (en) Method of treatment
GB9218188D0 (en) Method of treatment
GB9207275D0 (en) Method of treatment
HK1012247A (en) Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds
GB9226371D0 (en) Novel method of treatment
GB9101175D0 (en) Method of treatment
GB9101176D0 (en) Method of treatment
GB9101000D0 (en) Method of treatment